Literature DB >> 10755437

Extendible replacements of the proximal tibia for bone tumours.

R J Grimer1, M Belthur, S R Carter, R M Tillman, P Cool.   

Abstract

Limb salvage is now customary in the treatment of primary bone tumours. The proximal tibia is a frequent site for these neoplasms but reconstruction, especially in children, is a formidable challenge. We reviewed 20 children with extendible replacements of the proximal tibia, all with a minimum follow-up of five years. Five died from their disease and, of the remaining 15, four had above-knee amputations for complications. Infection occurred in seven patients; in five it was related to the lengthening procedure. Aseptic loosening is inevitable in the younger children and only two have avoided a revision, amputation or other major complication; both were aged 12 years at the time of the initial surgery. Despite this, 11 children are alive with a functioning leg and a mean Musculoskeletal Tumour Society functional score of 83%. The lengthening mechanisms used in our series required extensive open operations. We are now using a simpler, minimally invasive, technique which we hope will decrease the incidence of complications. At present, the use of extendible prostheses of the proximal tibia remains an experimental procedure.

Entities:  

Mesh:

Year:  2000        PMID: 10755437     DOI: 10.1302/0301-620x.82b2 .9863

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  14 in total

1.  Causes and Frequencies of Reoperations After Endoprosthetic Reconstructions for Extremity Tumor Surgery: A Systematic Review.

Authors:  Patrick Thornley; Matias Vicente; Austin MacDonald; Nathan Evaniew; Michelle Ghert; Roberto Velez
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

2.  Staged lengthening arthroplasty for pediatric osteosarcoma around the knee.

Authors:  Chang-Bae Kong; Soo-Yong Lee; Dae-Geun Jeon
Journal:  Clin Orthop Relat Res       Date:  2009-11-03       Impact factor: 4.176

3.  Continuous infusion of insulin-like growth factor-I into the epiphysis of the tibia.

Authors:  Aziz Abbaspour; Shinjiro Takata; Yoshito Matsui; Shinsuke Katoh; Mitsuhiko Takahashi; Natsuo Yasui
Journal:  Int Orthop       Date:  2007-03-13       Impact factor: 3.075

4.  Management of septic complications following modular endoprosthetic reconstruction of the proximal femur.

Authors:  Philipp T Funovics; Christian Hipfl; Jochen G Hofstaetter; Stephan Puchner; Rainer I Kotz; Martin Dominkus
Journal:  Int Orthop       Date:  2010-08-28       Impact factor: 3.075

5.  [Growing prostheses for reconstruction of lower limb defects in children].

Authors:  M Schinhan; P Funovics; M Dominkus; R Windhager
Journal:  Oper Orthop Traumatol       Date:  2012-07       Impact factor: 1.154

6.  What is the emotional acceptance after limb salvage with an expandable prosthesis?

Authors:  Eric R Henderson; Andrew M Pepper; German A Marulanda; Justin D Millard; G Douglas Letson
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

7.  Hemiarthroplasty of Pedicle-Frozen Proximal Tibia for Primary Malignant Bone Tumours.

Authors:  Suraj Hindiskere; Sreeraj Rajan; Utkarsh Pal; Pramatha P Dixit; Vaishnavi R Varma; Pramod S Chinder
Journal:  Indian J Orthop       Date:  2022-05-30       Impact factor: 1.033

8.  Risk of amputation following limb salvage surgery with endoprosthetic replacement, in a consecutive series of 1261 patients.

Authors:  L M Jeys; R J Grimer; S R Carter; R M Tillman
Journal:  Int Orthop       Date:  2003-02-08       Impact factor: 3.075

9.  Tibial Growth Disturbance Following Distal Femoral Resection and Expandable Endoprosthetic Reconstruction.

Authors:  Annie Arteau; Valerae O Lewis; Bryan S Moon; Robert L Satcher; Justin E Bird; Patrick P Lin
Journal:  J Bone Joint Surg Am       Date:  2015-11-18       Impact factor: 5.284

10.  Use of irradiated autologous bone in joint sparing endoprosthetic femoral replacement tumor surgery.

Authors:  Sridhar Vijayan; William Bartlett; Robert Lee; Peter Ostler; Gordon W Blunn; Stephen R Cannon; Timothy Wr Briggs
Journal:  Indian J Orthop       Date:  2011-03       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.